Litcius/Paper detail

Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

Atul Malhotra, Josef Bednařík, Sujatro Chakladar, Julia P. Dunn, Terri E. Weaver, Ronald R. Grunstein, Ingo Fietze, Susan Redline, Ali Azarbarzin, Scott A. Sands, Richard J. Schwab, Mathijs C. Bunck

2024Contemporary Clinical Trials73 citationsDOIOpen Access PDF

Topics & Concepts

MedicineObstructive sleep apneaPolysomnographyOverweightContinuous positive airway pressureRandomized controlled trialPhysical therapyBody mass indexPlaceboSleep apneaWeight lossClinical endpointObesityApnea–hypopnea indexApneaInternal medicineAlternative medicinePathologyObstructive Sleep Apnea ResearchBody Contouring and SurgeryBariatric Surgery and Outcomes
Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial | Litcius